CA3127667A1 - Production et utilisation d'extrait de levure en tant qu'adjuvant medical - Google Patents

Production et utilisation d'extrait de levure en tant qu'adjuvant medical Download PDF

Info

Publication number
CA3127667A1
CA3127667A1 CA3127667A CA3127667A CA3127667A1 CA 3127667 A1 CA3127667 A1 CA 3127667A1 CA 3127667 A CA3127667 A CA 3127667A CA 3127667 A CA3127667 A CA 3127667A CA 3127667 A1 CA3127667 A1 CA 3127667A1
Authority
CA
Canada
Prior art keywords
health
compound
subject
promoting compound
yeast extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3127667A
Other languages
English (en)
Inventor
Sean Farmer
Ken Alibek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Locus IP Co LLC
Original Assignee
Locus IP Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Locus IP Co LLC filed Critical Locus IP Co LLC
Publication of CA3127667A1 publication Critical patent/CA3127667A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A23L33/145—Extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des compositions et des procédés pour améliorer la biodisponibilité de composés favorisant la santé, tels que des produits pharmaceutiques et des suppléments nutritionnels. La présente invention utilise une composition d'adjuvant comprenant un extrait de levure pour améliorer la biodisponibilité de composés favorisant la santé et pour réduire le dosage efficace qui est nécessaire.
CA3127667A 2019-01-28 2020-01-27 Production et utilisation d'extrait de levure en tant qu'adjuvant medical Pending CA3127667A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962797599P 2019-01-28 2019-01-28
US62/797,599 2019-01-28
PCT/US2020/015144 WO2020159842A1 (fr) 2019-01-28 2020-01-27 Production et utilisation d'extrait de levure en tant qu'adjuvant médical

Publications (1)

Publication Number Publication Date
CA3127667A1 true CA3127667A1 (fr) 2020-08-06

Family

ID=71840598

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3127667A Pending CA3127667A1 (fr) 2019-01-28 2020-01-27 Production et utilisation d'extrait de levure en tant qu'adjuvant medical

Country Status (4)

Country Link
US (1) US20220096579A1 (fr)
EP (1) EP3908300A4 (fr)
CA (1) CA3127667A1 (fr)
WO (1) WO2020159842A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3085343A1 (fr) 2017-12-28 2019-07-04 Locus Ip Company, Llc Composition de sante buccale comprenant des biotensioactifs purifies et/ou leurs derives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH692837A5 (it) * 1997-07-02 2002-11-29 Lisapharma Spa Composizione farmaceutica per uso alimentare, dietetico o medicinale adatta a migliorare l'assorbimento orale dei polifenoli e particolarmente del resveratrolo presenti nell'uva e nei suoi p
WO1999049876A2 (fr) * 1998-03-31 1999-10-07 Abbott Laboratories Extraits bacteries ou de levures stimulant la production de defensines, et leur utilisation
CA2741621C (fr) * 2008-01-18 2019-08-20 Bio Processing Australia Pty Ltd Procede de preparation de produits nutritionnels, therapeutiques ou organoleptiques a partir de glycerol brut
EP2140772A1 (fr) * 2008-07-03 2010-01-06 Nestec S.A. Libération induite par la température de nutriments par des microorganismes dans le tractus gastrointestinal
CN102119772B (zh) * 2011-01-26 2015-04-08 深圳市多微生保健食品有限公司 一种保健口服液及其制造方法
CN102988981B (zh) * 2012-12-13 2015-03-04 中国水产科学研究院黄海水产研究所 一种增强爱德华氏菌疫苗免疫接种效果的佐剂及使用方法
WO2015061798A2 (fr) * 2013-10-25 2015-04-30 R.F. Technology Consultants, Inc. Compositions et procédés faisant appel à des organismes de type levures et à des extraits lipidiques de ceux-ci
US10238745B2 (en) * 2015-01-31 2019-03-26 Constance Therapeutics, Inc. Cannabinoid composition and products including α-tocopherol
US10827771B2 (en) * 2015-04-28 2020-11-10 Tablemark Co., Ltd. Method for producing yeast extract, yeast extract obtained thereby, seasoning composition, and food
WO2017068349A1 (fr) * 2015-10-23 2017-04-27 E-Therapeutics Plc Cannabinoïde pour utilisation en immunothérapie
EP3478844A4 (fr) * 2016-07-01 2020-04-08 International Flavors & Fragrances Inc. Compositions et procédés pour produire des terpénoïdes d'agrumes
EP3993780A4 (fr) * 2019-07-02 2023-07-26 Portland Technology Holdings LLC Extrait de chanvre pour le traitement de la douleur, du cancer et de l'epilepsie chez les animaux
EP4009954A4 (fr) * 2019-08-10 2023-07-26 Locus IP Company, LLC Procédés pour augmenter la biodisponibilité de médicaments pharmaceutiques et sans ordonnance ("otc")

Also Published As

Publication number Publication date
EP3908300A4 (fr) 2022-10-19
WO2020159842A1 (fr) 2020-08-06
US20220096579A1 (en) 2022-03-31
EP3908300A1 (fr) 2021-11-17

Similar Documents

Publication Publication Date Title
US11590231B2 (en) Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances
US6652891B2 (en) Co-enzyme Q10 dietary supplement
US11806375B2 (en) Nutritional support for animals via administration of an algal derived supplement
EP2050444B1 (fr) Agent de réduction de la fatigue
BRPI0709083A2 (pt) composições que compreendem porphyra e métodos de preparação e utilização destas
JP5927191B2 (ja) 全卵タンパク質ペプチド、その調製方法及び使用
JP2022132561A (ja) 加齢に伴う持続的注意力低下の改善用の組成物
JPH0920660A (ja) 抗ストレス組成物
KR101371143B1 (ko) 클로렐라를 유효성분으로 포함하는 간기능 개선 또는 숙취해소용 조성물
CA3127667A1 (fr) Production et utilisation d'extrait de levure en tant qu'adjuvant medical
JP4000946B2 (ja) 冬虫夏草の新規製造方法及び得られた冬虫夏草とその使用
JP7475155B2 (ja) 持久力向上用組成物
JP2004083526A (ja) 抗ウイルス組成物
EP4082555A1 (fr) Agent d'inhibition des troubles des vaisseaux sanguins capillaires, agent d'amélioration des troubles des vaisseaux sanguins capillaires, et agent d'accélération d'angiogenèse capillaire
CN117122620B (zh) Akkermansia muciniphila在制备预防、治疗和/或辅助治疗关节炎的产品中的应用
US20240009259A1 (en) Use of crassocephalum rabens extract in the prevention and/or treatment of fatigue and/or depression
JP2004083527A (ja) 抗ウイルス組成物
JP6193176B2 (ja) 活力及び／又は集中力向上剤
KR20230127927A (ko) 면역증강 효능이 증대된 녹용 발효물의 제조방법
KR20040035985A (ko) 성장 호르몬의 발현 및 증체량을 증가시키는 성장 촉진용조성물
TW202103724A (zh) 黑豆發酵物用於製備抗疲勞醫藥品之用途
JP2003146873A (ja) 鉄吸収促進剤
JP2004210729A (ja) アセトアルデヒド代謝促進剤
JP2015214516A (ja) 活力及び／又は集中力向上剤
JP2004083525A (ja) 抗ウイルス組成物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220728

EEER Examination request

Effective date: 20220728

EEER Examination request

Effective date: 20220728

EEER Examination request

Effective date: 20220728

EEER Examination request

Effective date: 20220728